← Back to Search

Patients receiving solid oral medication as a standard of care. for Pill (RegStud Trial)

N/A
Recruiting
Led By David Waterhouse, MD
Research Sponsored by Dosentrx Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 weeks
Awards & highlights

RegStud Trial Summary

The goal of this observational study is to evaluate the safety, efficacy and patient satisfaction with the ReX Remote Digital Nurse by patients receiving solid oral medication. The study will evaluate and monitor use of ReX in respect of: treatment duration adverse events patient adherence and compliance engagement with ReX via patient-reported outcomes Patients participating in the study will receive their normal medication as standard of care via ReX. Progress will be monitored via patients' responses to questions presented on the ReX touch screen.

RegStud Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adverse events
Patient adherence
Patient compliance
+3 more

RegStud Trial Design

1Treatment groups
Experimental Treatment
Group I: Patients receiving solid oral medication as a standard of care.Experimental Treatment1 Intervention
Solid oral medication administered via the ReX Remote Digital Nurse.

Find a Location

Who is running the clinical trial?

US Oncology ResearchIndustry Sponsor
37 Previous Clinical Trials
16,462 Total Patients Enrolled
Dosentrx Ltd.Lead Sponsor
5 Previous Clinical Trials
400 Total Patients Enrolled
David Waterhouse, MDPrincipal InvestigatorUS Oncology

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~667 spots leftby Dec 2025